| TITLE | Journal/Meeting | Decision | Authors | DOI |
| Oral direct-acting agent therapy for Hepatitis C: A Systematic Review | Annals of Internal Medicine | Accepted Feb2017 | Oluwseun Falade-Nwulia MBBS, MPH,1*; Catalina Suarez-Cuervo MD2*, David R. Nelson MD3, Michael W. Fried MD4, Jodi B. Segal MD, MPH2, and Mark S. Sulkowski MD1 | DOI: 10.7326/M16-2575 |
| THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders | EASL2019 | Accepted POSTER | Sulkowski, MS; Moon, J; Sherman, K; Darling, J; Muir, A; Khalili, M; Fishbein, D; Hinestrosa, F; Shiffman, ML; Di Bisceglie, AM; Reddy, RK; Pearlman, B; Lok, AS; Fried, MW; Stewart, P; Peter, J; Wadsworth, S; Vainorius, M; Michael, L; Evon, D, Segal, J; and Nelson DR on behalf of the PRIORITIZE study team | |
| Experiences of an HCV Patient Engagement Group: A Seven-Year Journey | Research Involvement and Engagement | Accepted 11.6.2020 | Kixmiller, Brown, Chaney, Franciscus, Huston, Thomas, and Wadsworth | DOI: 10.1186/s40900-021-00249-2 |
| A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study | Hepatology | Accepted Hepatology Epub 2021 Aug 26 | Sulkowski, Moon, Sherman, Morelli, Darling, Muir, Khalili, Fishbein, Hinestrosa, Shiffman, Di Bisceglie, Reddy, Pearlman, Lok, Fried, Stewart, Peter, Wadsworth, Kixmiller, Sloan, Vainorius, Horne, Michael, Dong, Evon, Segal, Nelson D | DOI: 10.1002/hep.32053 |
| Formulary Restrictions May Impact Enrollment in Pragmatic Trials and Limit Generalizability of Findings to Vulnerable Populations | Clinical Trials | Accepted 5.4.2020 | Jodi B. Segal | DOI: 10.1177/1740774520941257 |
| Long-term follow-up of hepatitis C patients who achieved sustained virologic response in the pragmatic PRIORITIZE Study | Clinical Gastroenterology and Hepatology | Accepted 1.26.2022 (CGH-D-21-02843R1) | Anna S Lok; Juhi Moon; Kenneth E Sherman; Mandana Khalili; Dawn Fishbein; K. Rajender Reddy; on behalf of the PRIORITIZE Study Team | pending |